News & Views
Lab researchers study breast cancer prevention agent
Mar 24 2010
Scott & White Healthcare researchers are hoping clinical trials will help to discover whether metastasised tumours can be managed through the treatment.
According to the organisation, patients who have the disease and are not benefiting from existing medical assistance may be eligible for Phase II of the experiments.
Dr Christopher Ruud, director of the institution's breast cancer division, said the "ultimate goal" is to offer individuals a way of coping with the condition on a day-to-day basis.
He stated: "That is one of our strategies at Scott & White to find ways to treat breast cancer that has failed other treatments."
A recent study by Danish experts questioned whether breast screening has had a positive effect on the number of deaths relating to breast cancer.
Karsten Jorgensen and Peter Gotzsche from the Nordic Cochrane Centre in Copenhagen suggested tests of this kind had a minimal impact on reducing mortality rates.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria